Cambridge Investment Research Advisors’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.4M Sell
222,894
-6,607
-3% -$160K 0.01% 923
2025
Q4
$5.56M Sell
229,501
-10,204
-4% -$247K 0.01% 869
2025
Q3
$5.83M Buy
239,705
+11,685
+5% +$283K 0.02% 827
2025
Q2
$5.53M Buy
228,020
+5,923
+3% +$143K 0.02% 796
2025
Q1
$5.38M Buy
222,097
+48,860
+28% +$1.18M 0.02% 768
2024
Q4
$4.17M Buy
173,237
+17,877
+12% +$431K 0.01% 904
2024
Q3
$3.77M Buy
155,360
+38,668
+33% +$931K 0.01% 959
2024
Q2
$2.78M Buy
116,692
+31,270
+37% +$743K 0.01% 1074
2024
Q1
$2.04M Buy
85,422
+11,463
+15% +$273K 0.01% 1250
2023
Q4
$1.77M Sell
73,959
-15,255
-17% -$358K 0.01% 1283
2023
Q3
$2.08M Sell
89,214
-59,796
-40% -$1.4M 0.01% 1113
2023
Q2
$3.5M Buy
149,010
+11,472
+8% +$271K 0.02% 840
2023
Q1
$3.26M Buy
137,538
+63,818
+87% +$1.5M 0.02% 845
2022
Q4
$1.72M Buy
73,720
+11,613
+19% +$270K 0.01% 1168
2022
Q3
$1.44M Buy
62,107
+53,463
+618% +$1.27M 0.01% 1246
2022
Q2
$206K Buy
+8,644
New +$208K ﹤0.01% 2701
2021
Q3
Sell
-17,482
Closed -$465K 3139
2021
Q2
$465K Sell
17,482
-40
-0.2% -$1.06K ﹤0.01% 2113
2021
Q1
$462K Buy
17,522
+3,854
+28% +$103K ﹤0.01% 1954
2020
Q4
$370K Buy
13,668
+1,263
+10% +$34K ﹤0.01% 1981
2020
Q3
$333K Sell
12,405
-672
-5% -$18.1K ﹤0.01% 1867
2020
Q2
$349K Sell
13,077
-253
-2% -$6.54K ﹤0.01% 1768
2020
Q1
$327K Buy
13,330
+3,770
+39% +$95.8K ﹤0.01% 1619
2019
Q4
$244K Buy
+9,560
New +$243K ﹤0.01% 2065
2019
Q3
Sell
-10,396
Closed -$261K 2376
2019
Q2
$261K Buy
10,396
+113
+1% +$2.76K ﹤0.01% 1834
2019
Q1
$249K Buy
+10,283
New +$243K ﹤0.01% 1925

Other funds holding IBDR

Cambridge Investment Research Advisors's IBDR Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 2.9% in Q1 2026, selling an estimated $160K and leaving 222,894 shares worth $5.4M. The position accounts for 0.01% of the portfolio, ranked #923.

Cambridge Investment Research Advisors first reported a position in IBDR in Q1 2019 and has held it in 25 quarters since. The position peaked at $5.83M in Q3 2025. 439 funds tracked by Wall St. Rank hold IBDR as of Q1 2026.

  • Cambridge Investment Research Advisors held 222,894 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $5.4M as of Q1 2026.
  • Cambridge Investment Research Advisors sold 6,607 iShares iBonds Dec 2026 Term Corporate ETF shares in Q1 2026, an estimated $160K.
  • iShares iBonds Dec 2026 Term Corporate ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #923 holding.
  • Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q1 2019 and has held it in 25 quarters since.
  • Cambridge Investment Research Advisors's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $5.83M in Q3 2025.
  • 439 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.